Vagal stimulation in heart failure.
Heart failure (HF) is accompanied by an autonomic imbalance that is almost always characterized by both increased sympathetic activity and withdrawal of vagal activity. Experimentally, vagal stimulation has been shown to exert profound antiarrhythmic activity and to improve cardiac function and survival in HF models. A open-label pilot clinical study in 32 patients with chronic HF has shown safety and tolerability of chronic vagal stimulation associated with subjective (improved quality of life and 6-min walk test) and objective improvements (reduced left ventricular systolic volumes and improved left ventricular ejection fraction). Three larger clinical studies, including a phase III trial are currently ongoing and will evaluate the clinical role of this new approach.
Department of Cardiology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19, 27100, Pavia, Italy, g.deferrari@smatteo.pv.it.
Gaetano M
GM
De Ferrari
D000818:Animals; D001341:Autonomic Nervous System / Q000503:physiopathology*; D017704:Baroreflex / Q000502:physiology; D004195:Disease Models, Animal; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D014630:Vagus Nerve / Q000502:physiology / Q000503:physiopathology*; D055536:Vagus Nerve Stimulation / Q000379:methods*